Intellectual Property and Emerging Technologies

Intellectual Property and Emerging Technologies

The New Biology

Queen Mary Studies in Intellectual Property series

Edited by Matthew Rimmer and Alison McLennan

This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery.

Chapter 7: Building with BioBricks: Constructing a Commons for Synthetic Biology Research

Alison McLennan

Subjects: economics and finance, environmental economics, environment, biotechnology, environmental economics, innovation and technology, technology and ict, law - academic, intellectual property law


Alison McLennan On 21 May 2010, scientists at the J Craig Venter Institute in the United States announced that they had made a ‘self-replicating synthetic bacterial cell’.1 This achievement is the most famous outcome of synthetic biology, a burgeoning new field of biotechnology research. The achievement was made possible by our increasing ability to build DNA from its components and to stitch it together to form synthetic genomes. The disciplines of molecular biotechnology, chemical engineering, genomics, and information technology converge in this new field of synthetic biology. With its promise of improved medical treatments and greener energy sources, along with its potential risks of bioterrorism and damage to the environment or human health, synthetic biology has been increasingly capturing the public imagination and attracting government and commercial attention. This excitement reached a crescendo with the announcement of the successful construction of the synthetic bacterial cell. Even the United States President Barack Obama joined the ensuing debate, asking his Presidential Commission for the Study of Bioethical Issues to investigate synthetic biology.2 This chapter will provide an overview of the field of synthetic biology, focusing in particular on the branch of synthetic biology that uses ‘standard biological parts’. The chapter will then address the approach to intellectual property, sharing and commons development in this ‘parts agenda’. 1 2 Gibson, D. et al. (2010), ‘Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome’, Science, 329 (5987), 52–6. Their report was released in December 2010: The Presidential Commission for the Study...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information